Stocks
Laboratory Corporation of America Holdings Financial Statements (LH) |
||||||||||
| Laboratory Corporation of America Holdingssmart-lab.ru | % | 2023Q2 | 2023Q3 | 2023Q3 | 2023Q4 | 2023Q4 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 30.10.2023 | 15.02.2024 | 26.02.2024 | 25.04.2024 | 30.04.2024 | 30.04.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 3 057 | 3 033 | 3 033 | 3 177 | 3 177 | 12 420 | |||
| Operating Income, bln rub | 252.3 | -122.8 | 229.3 | 328.8 | 328.8 | 764.1 | ||||
| EBITDA, bln rub | ? | 436.7 | -122.8 | 375.7 | 483.3 | 483.3 | 1 220 | |||
| Net profit, bln rub | ? | 183.3 | -167.1 | -167.1 | 228.0 | 228.0 | 121.8 | |||
| OCF, bln rub | ? | 275.5 | 579.6 | 579.6 | -29.8 | 1 129 | ||||
| CAPEX, bln rub | ? | 104.9 | 165.4 | 167.2 | 133.8 | 466.4 | ||||
| FCF, bln rub | ? | 170.6 | 414.2 | 412.4 | -163.6 | 663.0 | ||||
| Dividend payout, bln rub | 63.9 | 61.1 | 61.1 | 62.1 | 184.3 | |||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 34.9% | 0.00% | 0.00% | 0.00% | 27.2% | 151.3% | ||||
| OPEX, bln rub | 581.2 | 532.9 | 532.9 | 508.4 | 508.4 | 2 083 | ||||
| Cost of production, bln rub | 2 206 | 2 212 | 2 271 | 2 339 | 2 339 | 9 162 | ||||
| R&D, bln rub | 0.000 | 0.000 | 2.00 | 0.000 | 0.000 | 2.00 | ||||
| Interest expenses, bln rub | 50.3 | 48.8 | 48.8 | 46.9 | 46.9 | 191.4 | ||||
| Assets, bln rub | 16 886 | 16 725 | 16 725 | 16 531 | 16 531 | 16 531 | ||||
| Net Assets, bln rub | ? | 7 873 | 7 875 | 7 875 | 7 960 | 7 960 | 7 960 | |||
| Debt, bln rub | 6 330 | 5 954 | 5 954 | 5 969 | 5 969 | 5 969 | ||||
| Cash, bln rub | 727.9 | 536.8 | 536.8 | 99.3 | 99.3 | 99.3 | ||||
| Net debt, bln rub | 5 602 | 5 417 | 5 417 | 5 869 | 5 869 | 5 869 | ||||
| Ordinary share price, rub | 201.1 | 227.3 | 227.3 | 218.5 | 218.5 | 199.0 | ||||
| Number of ordinary shares, mln | 86.6 | 84.9 | 84.9 | 84.1 | 84.1 | 84.1 | ||||
| Market cap, bln rub | 17 411 | 19 297 | 19 297 | 18 372 | 18 372 | 16 733 | ||||
| EV, bln rub | ? | 23 013 | 24 714 | 24 714 | 24 242 | 24 242 | 22 603 | |||
| Book value, bln rub | -1 734 | -1 610 | -1 610 | -1 653 | -1 653 | -1 653 | ||||
| EPS, rub | ? | 2.12 | -1.97 | -1.97 | 2.71 | 2.71 | 1.45 | |||
| FCF/share, rub | 1.97 | 4.88 | 4.86 | 0.00 | -1.95 | 7.88 | ||||
| BV/share, rub | -20.0 | -19.0 | -19.0 | -19.7 | -19.7 | -19.7 | ||||
| EBITDA margin, % | ? | 14.3% | -4.05% | 12.4% | 15.2% | 15.2% | 9.82% | |||
| Net margin, % | ? | 6.00% | -5.51% | -5.51% | 7.18% | 7.18% | 0.98% | |||
| FCF yield, % | ? | 4.15% | 5.61% | 5.60% | 5.88% | 4.99% | 3.96% | |||
| ROE, % | ? | 12.5% | 5.00% | 5.00% | 7.81% | 7.81% | 1.53% | |||
| ROA, % | ? | 5.84% | 2.36% | 2.36% | 3.76% | 3.76% | 0.74% | |||
| P/E | ? | 17.6 | 49.0 | 49.0 | 29.5 | 29.5 | 137.4 | |||
| P/FCF | 24.1 | 17.8 | 17.9 | 17.0 | 20.0 | 25.2 | ||||
| P/S | ? | 1.04 | 1.59 | 1.59 | 1.20 | 1.20 | 1.35 | |||
| P/BV | ? | -10.0 | -12.0 | -12.0 | -11.1 | -11.1 | -10.1 | |||
| EV/EBITDA | ? | 10.2 | 21.7 | 15.1 | 11.4 | 11.4 | 18.5 | |||
| Debt/EBITDA | 2.47 | 4.76 | 3.31 | 2.77 | 2.77 | 4.81 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 1.20% | 0.00% | 0.43% | |||||
| CAPEX/Revenue, % | 3.43% | 5.45% | 5.51% | 0.00% | 4.21% | 3.76% | ||||
| Laboratory Corporation of America Holdings shareholders | ||||||||||
